SUMMARY Several experimental procedures produce dramatic alterations in kidney renin production, leading to increased plasma renin levels with attendant hypertension in animal model systems. The pattern of changes for kidney renin messenger RNA (mRNA) levels relative to changes for tissue and plasma renin activity was studied in Sprague-Dawley rats made hypertensive by either coarctation of the aorta between the two renal arteries or clipping of the left renal artery. In both models, the renin mRN A content of the contralateral hypertrophled kidney transiently decreased to undetectable levels while the ischemic kidney exhibited transient increases in renin mRN A. In aorta-coarctated rats ischemic kidney renin mRNA increased 10-fold to 16-fokl during the first 3 days after coarctation but returned to the level observed in sham-operated rats 14 days after operation. However, differences between the time course and magnitude of changes in renin mRNA levels and the pattern of alteration in tissue and plasma renin activities were observed. Thus, although the kidney renin mRNA transiently increased in hypertensive animals, the extent of this increase was insufficient to account for the 30-fold to 50-fold increases in plasma renin activity. Similarly, the transient increase in kidney renin mRNA was inconsistent with only a twofold increase in tissue renin enzyme activity of the ischemic kidney. These data indicate that in addition to alterations in the kidney renin mRNA pool, posttranslational processing and/or release of renin from the kidney are cocontributors in regulating the plasma renin levels in these experimental models. (Hypertension 8: 874-882, 1986) 
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hypertensive by placing a 0.2-mm silver clip on the left renal artery (two-kidney, one clip; 2K1C). 4 All control rats were subjected to sham operations. All operations were performed with the rats under amobarbital (Amytal) anesthesia. Rats were weighed twice weekly until they were killed, and the blood pressure and heart rate of 2K1C rats monitored by the tail-cuff method. Blood pressure and heart rate measurements were performed on rats subjected to aortic coarctation after catheterization of the right carotid artery. Catheters were implanted with the rats under amobarbital (Amytal) anesthesia, and measurements were made 2 to 3 hours after the rats regained consciousness.
All rats were killed by decapitation, and their blood was collected on ice. To minimize the effects of amobarbital (Amytal) anesthesia on plasma and tissue renin enzyme activities, rats subjected to catheterization of their right carotid artery were killed approximately 5 hours after they regained consciousness. The heart (ventricles), kidneys, and thymus were quickly removed, placed on ice, and weighed. Uniform midlongitudinal sections (approximately 1.0 mm thick, containing a representative section of kidney cortex) were taken from each kidney, frozen on dry ice, and stored at -80°C for subsequent tissue renin enzyme determinations. The remaining pieces of kidney tissue were reweighed and immediately homogenized for RNA extraction. Plasma, serum, and kidney tissue samples were frozen at -80 °C until assayed for renin enzyme activity.
Renin Enzyme Activity
Renin enzyme activity was determined 3 for each plasma and kidney tissue sample in the presence of excess exogenous angiotensinogen (approximately 5 X 10~4 M) and protease inhibitors. Kidney slices were quickly thawed in 5 ml of ice-cold 100 mM sodium phosphate buffer, pH 6.5 (containing the following protease inhibitors: 5 mM ethylenediaminetetraacetic acid, 5.0 mM iV-ethylmaleimide, and 1.0 mM phenylmethylsulfonylfluoride), and homogenized using a polytron (Brinkmann Instruments, Westbury, NY, USA). Homogenized tissue was then frozen and thawed twice, aliquoted, and frozen at -80°C until assay. Before renin enzyme activity determinations, freshly thawed aliquots of plasma or tissue homogenate were centrifuged at 20,000 g for 5 minutes. A dilution series of each sample was made using homogenization buffer and added to partially purified rat angiotensinogen (4 fig ANG I equivalents/mg protein; final concentration 5 X 10~4 M ANG I equivalents). The ANG I was assayed after incubation for 1 hour at 37 °C using the New England Nuclear ANG I assay kit (Boston, MA, USA). Endogenous ANG I levels (0 minutes of incubation) were subtracted from each dilution sample, and the resultant ANG I concentration was plotted against the volume of original sample assayed. The slope of the curve (line derived from 3 to 4 data points) was taken as the renin enzyme activity of that sample; two to three independent assays (using freshly thawed aliquots for each determination) were performed on each sample, and values varying by less than 10% were averaged.
RNA Purification
Kidney tissue was homogenized using a polytron in 4.0 M guanidine thiocyanate, 1.0 M /3-mercaptoethanol, and the RNA was recovered by centrifugation through a 5.7 M cesium chloride cushion. 67 Pelleted kidney RNA was dissolved in 4.0 M guanidine HC1 and precipitated with ethanol. Purified RNA was twice precipitated with ethanol prior to Northern blot analysis. The amount of RNA recovered was measured by absorbance at 260 nm.
Molecular Hybridization
Renin mRNA was quantitated by Northern blot analysis using a modification of the method of Thomas 8 ; 20 fig of total kidney RNA was analyzed per lane. Two different hybridization probes were used. The RNA from 2K1C animals was hybridized with a double-stranded probe prepared by nick-translating the insert of pDD-lD2 as described by Field et al.' This insert was derived from a full-length cDNA copy of DBA/2J mouse submandibular gland (SMG) renin mRNA. The RNA from animals subjected to aortic coarctation was also hybridized with a complementary single-stranded RNA probe prepared by transcription of a 922 base pair (bp) subfragment of the pDD-lD2 insert transferred into SP64 (Promega Biotech, Madison, WI, USA). Both probes yielded comparable Northern blot profiles; however, the SP64 riboprobe exhibited a greater signal intensity following hybridization. The reaction mixture contained 40 mM tris(hydroxymethyl) aminomethane HC1, pH 7.5, 6 mM MgCl 2 , 4 mM spermidine, and 10 mM NaCl. Linearized plasmid, 250 ng, was incubated with 20 U of SP64 RNA polymerase in the presence of 8 fiM amount of kidney RNA recovered in each preparation, which was corrected by the proportion of the kidney used in the RNA extraction.
Results
Characterization of Model Systems
A number of measurements were made on each rat subjected to aortic coarctation or renal artery clipping as well as on sham-operated control rats to establish the development and degree of hypertension. These measurements included body, heart (ventricles), thymus, and kidney weights; heart rate and blood pressure; kidney and plasma renin activity (PRA, both measured in the presence of excess renin substrate); and blood urea nitrogen.
Consistent with the observations of Chatelain et al. , 3 all aorta-coarctated rats showed 1) marked elevations of mean blood pressure (Table 1 ) with no significant increase in heart rate (data not shown), 2) increases in heart/body weight ratios (see Table 1 ), and 3) impaired kidney function, as evidenced by a 1.5-fold to threefold elevation of blood urea nitrogen values (control value approximately 18 mg/dl). We used the criteria of Chatelain et al. , 3 segregating the rats into subgroups on the basis of the severity of their response to aortic coarctation. Thus, aorta-coarctated rats that gained little or no weight following operation (see Table 1 ), -124  178  168  144  176  204  122  194  168  121  172  198  196  140  160  220  124  184  188  156  124  198  204  196  130  218  210  128  170  212   170  122  131  188  126  149  210  157  185  220  149  176  240  175  133  187  280  168  215  262  213  163  218  303  266  231  301  315  260  292  360 •Measured by means of carotid artery catheterization 3 hours after recovery from anesthesia. Blood pressure of 3-day rats was not measured. Lig = ligation (coarctation of the aorta between the two renal arteries). exhibited thymus atrophy of over 50% (see Table 1 ), and exhibited elevated plasma renin enzyme activities of over 10-fold ( Figure 1A , striped areas) were considered to exhibit severe responses. Rats that regained weight following operation (see Table 1 ), exhibited relatively less thymic atrophy (<50%), and showed less than a 10-fold increase in PRA (see Figure 1A , solid area) were considered to exhibit a moderate response to aortic coarctation. 3 Alterations in kidney renin mRNA levels were also documented in a second experimental model of renal hypertension, the 2K1C rat model. As shown in Table  2 and Figure 2 , most 2K1C rats exhibited elevations in PRA less than fourfold over sham-operated control levels while some rats (Rat 3, Day 28) failed to manifest elevated blood pressures. Two rats (Rat 1, Day 28, and Rat 2, Day 41) exhibited marked elevations in PRA (see Figure 2) , little postsurgical increase in body weight, and heart hypertrophy ( Table 2 ). Unlike rats with aortic coarctation, rats with clips placed on their left renal arteries did not exhibit severe atrophy of the thymus.
KIDNEY RENIN MESSENGER KNA/Moffett et al.
S I 2 S I 2 S I 2 S I 2 S I 2 3 S I 2 S I 2 3 S I 2 3 S I 2 S I
Renin Messenger RNA Content of Kidneys Samples (20 /ig/gel lane) of total RNA (20 fig) extracted from each kidney were analyzed by Northern blot hybridization to quantitate levels of renin mRNA ( Figure 3 ). As reviewed in Methods, standard RNA samples were incorporated into each gel to control for variation in Northern blots caused, by differences in probe-specific activity, hybridization, and autoradiogram development.
Sham-operated Controls
Examination of Northern blots showed that the renin mRNA band intensities of each sham-operated rat's right and left kidney were approximately equal ( Figure  3 ). This correlates with the approximately equivalent 
Tail cuff measurements. Clip = two-kidney, one clip. levels of tissue renin enzyme activity in the left and right kidneys of sham-operated control rats (see Figures IB and 2B) .
During the postoperative survival period, however, sham-operated rats in both experimental series exhibited substantial growth (see Tables 1 and 2 ); this growth was reflected in increases in total kidney RNA recovered (data not shown) as well as in the normalized total (right plus left) kidney renin mRNA detected. As visualized in Figure 4A , the total kidney content of renin mRNA in the sham-operated rats (aortic coarctation series) increased substantially during the 35-day survival period, while body weight increased from 160 to 360 g and kidney weight increased from 0.7 to 1.2 g during this same period (see Table 1 ).
Aortic Coarctation Model
Rats subjected to aortic coarctation exhibited a dramatically different pattern of kidney renin mRNA expression (see Figure 3A and B) and tissue renin content (see Figure IB ) compared with that in sham-operated rats. By 3 days postcoarctation (see Figure 3 ; Figure  4C ) a substantial reduction in renin mRNA was evident in the contralateral kidney, even as these kidneys underwent hypertrophy (see Table 1 ). Concurrent with this apparent disappearance of renin mRNA from the contralateral kidney, tissue renin enzyme activity was also reduced (see Figure IB) . This reduction in contralateral kidney enzyme activity, however, lagged the reduction in renin mRNA; contralateral tissue renin levels did not reach a minimum until 5 days postcoarctation (see Figure IB) . After 5 days postcoarctation, contralateral kidney tissue levels of renin enzyme activity remained low (see Figure IB ) in all rats even though renin mRNA became detectable in this kidney during the second and third weeks postoperation (see Figure 4C ).
In contrast, as the ischemic kidney atrophied (see Table 1 ), increased levels of renin mRNA and tissue levels of renin were apparent. By 3 days postcoarctation, ischemic kidneys exhibited substantially more renin enzyme activity (see Figure IB) and relatively higher levels of renin mRNA (see Figures 3A and B and 4C) than sham-operated control or aorta-coarctated contralateral kidneys. Figure 4B summarizes the temporal changes in renin mRNA content in the right plus left kidney of coarctated rats. Since PRA level (see Figure 1A) is a net result of the synthesis and release of renin from both kidneys, temporal alterations in total (right plus left) kidney renin mRNA are compared with PRA of rats in the coarctation series. After renin mRNA was normalized to levels observed in control rats, an early, transient increase in total kidney renin mRNA was evident. In 3-day coarctated rats, sixfold to eightfold increase in total renin mRNA over controls was observed (12-fold to 16-fold in the left kidney alone); PRA increased 30-fold to 50-fold (see Figure 1A) , and tissue renin enzyme activity increased less than twofold (see Figure IB) .
From Days 3 to 11 postcoarctation, there was a significant decline in renin mRNA with subsequent FIGURE (1, 2, 3 Figure 1 for key to abbreviations. 
Plasma renin activity (A) and kidney tissue renin activity (B) in rats with clipped left renal arteries
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stabilization below control levels (see Figure 4B ). In contrast, both tissue and plasma renin enzyme activities remained elevated (see Figure 1) . Similarly, the 30-fold to 50-fold increase in PRA observed shortly after coarctation was maintained in the 13-day survival group despite the decline in mRNA. The PRA declined to lower, near normal, levels during the third to fifth weeks postoperation, but total renin mRNA decreased to half that observed in control animals. The decline in total renin mRNA (see Figure 4B ), while partly due to atrophy of the ischemic kidney (see Table 1 ), represented a decrease in the relative as well as the absolute concentration of renin mRNA in this kidney. However, the ischemic kidney decline was offset by the reappearance and subsequent increase of renin mRNA in the contralateral kidney (see Figure  4C) . Although little or no renin mRNA was detected in the contralateral kidney during the first week postcoarctation, renin mRNA content in this kidney rose during the second to third week and subsequently composed an increasing proportion of the total renal renin mRNA.
Two-Kidney, One Clip Model
Although similar to the aorta-coarctated rats, the 2K1C rats exhibited a more variable response (see the 28-day survival group in Table 2 , Figures 2 and 3C ). Some 2K1C rats (Rat 3, Day 28) did not respond to the clipping procedure; they exhibited neither increases in blood pressure (see Table 1 ), PRA, or tissue renin activity (see Figure 2 ) nor any differences in the relative amount of renin mRNA found in their right and left kidneys (see Figure 3C ). Other 2K1C rats (Rat 1, Day 28), however, were similar to the aorta-coarctated rats; they exhibited blood pressures in excess of 200 mm Hg, PRA 30-fold to 50-fold above controls, elevated ischemic kidney renin enzyme content, and dramatic differences in right and left kidney renin mRNA levels. Such rats also tended to exhibit a retarded growth rate (low body weight) and atrophy of the thymus (see Table 1 ). However, the responses of 2K1C rats, as measured by renin mRNA, tissue renin levels, and PRA, tended to be less severe than similar responses of the aorta-coarctated rats (see Rat 2, Day 28).
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A. 
Discussion
We have monitored the temporal pattern of kidney renin mRNA levels in rats at various stages of experimentally induced renal hypertension in two model systems. Since similar alterations in renin mRNA levels were observed in both models, it is probable that such alterations in kidney renin mRNA levels are characteristic of renal hypertension. In the model systems investigated, renin mRNA levels in the contralateral and ischemic kidneys underwent opposite alterations, and statistically significant alterations were observed in the shortest time intervals examined. These results support the thesis that regulation of renin mRNA levels contributes to observed decreases and increases in renin synthesis and production in the contralateral and ischemic kidney, respectively. The precise mechanisms operating to achieve such modulations are as yet unclear. Differences in the extent and temporal sequence of alterations in renin mRNA levels, kidney renin enzyme activity, and PRA indicate that changes in renin protein processing, 10 release, and/or activation" also occur in the hypertensive rats. Although alterations in renin mRNA levels undoubtedly contribute to alterations in kidney renin production, they alone cannot account for the amplified and prolonged elevations in PRA that were observed.
As reviewed by Keeton and Campbell, 1 there is considerable evidence that the release of renin from the contralateral kidney is inhibited by coarctation or clipping. One unanswered question, however, is what happens to the renin stored within the juxtaglomerular cells of this kidney? When plasma and kidney pools of renin are compared, the bulk of the renin (by several thousand fold) is found in the kidney (see Figures 1 and  2 ). In fact, our estimates of tissue renin may be low; since detergents were not used in the extraction of renin from the kidneys, "membrane bound" renin may not have been included in our measurements. If one assumes that the 12-to 13-minute half-life of plasma renin as measured in mouse 12 is similar to that of rat and if the turnover of plasma renin is balanced by release of renin from the kidney, then 100 to 200 days would be required for the "normal" turnover (depletion) of the kidney renin pool that we measured. We observed, however, that kidney renin enzyme activity doubled in ischemic kidney and was considerably depleted in the contralateral kidney within 3 days of aortic coarctation. Since it is unlikely that contralateral kidney renin is being released into the blood, it may be that a substantial quantity (indeed the bulk) of kidney renin is not released as an active enzyme from the kidney but rather is inactivated, is degraded within the kidney, or becomes membrane bound. If such inactivation or degradation occurs within the contralateral kidney in such model systems and is also a "normal" aspect of juxtaglomerular cell renin metabolism, then this metabolic event could be important in regulating the ultimate PRA level. Currently, we are examining the synthesis and posttranslational metabolism of kidney renin in these model systems.
The reduced left kidney blood flow in both the ligated and clipped rats induces ischemia and stimulates release of renin by this kidney. 1 Unlike the contralateral kidney, the stored pools of renin in the ischemic kidney are probably a source of increased circulating renin found in the plasma of these rats. Thus, even in those rats exhibiting the greatest increase in ischemic kidney renin mRNA, a higher, nonproportionate increase in PRA is observed, resulting in what appears to however, tissue renin activity is not depleted but actually increases slightly. We speculate that this amplified response occurs in one of three ways: 1) a shift in the posttranslational processing of the renin enzyme could result in the production of a renin enzyme with a higher specific activity; 2) a greater proportion of the renin synthesized by the kidney could be released into the circulation as active enzyme; or 3) the half-life of the renin enzyme in plasma may be increased. To address these questions, renin "protein" must be examined directly. Currently, a library of monoclonal antibodies for various forms of renal and plasma renin is being produced to facilitate such investigations. In summary, we found that an early and dramatic reduction in the renin mRNA content of the contralateral kidney occurs during the initial phase of experimentally induced renal hypertension. This reduction in renin mRNA correlates with a reduction in tissue renin activity. During the transition to the chronic stage of renal hypertension, however, renin mRNA, but not renin enzyme activity, was again observed in the contralateral kidney. Hypertensive rats that showed pronounced elevations in PRA exhibited only a transient increase in renin mRNA in their ischemic kidney during the initial phase of hypertension. The kidney content of renin mRNA declined, however, before reductions in renin enzyme activity. Finally, the total renin mRNA present in the right plus left kidney ultimately fell below levels observed in control rats. This decrease occurred in spite of continued elevations in PRA lasting several weeks. Thus, while alterations in kidney renin mRNA levels undoubtedly contribute to alterations in kidney renin production, changes in renin protein processing, release, and/or activation must also occur in hypertensive rats to account for the amplified and prolonged elevations in PRA.
be amplified PRA levels. For instance, whereas ischemic kidney renin mRNA can increase 12-fold to 16-fold, total renin mRNA observed in both kidneys (i.e., right plus left) increases only sixfold to eightfold and PRA increases 30-fold to 50-fold. At the same time, R B Moffett, R A McGowan and K W Gross hypertension.
Modulation of kidney renin messenger RNA levels during experimentally induced
